A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) ...

Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

e20025Background: Lung cancer remains a leading cause of cancer-related mortality worldwide. Early detection significantly improves survival rates. In our previous study, we developed a machine ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms ...

The artificial intelligence method was used to optimize an early cancer detection test to ensure high sensitivity and specificity.

In this groundbreaking study funded by Cancer Research UK, co-authors Black and Bartha et al. highlight advancements in lung cancer detection using NeXT Personal®, an ultra-sensitive personalized ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had low-dose CT screening, in London.

We designed NeXT Personal to detect residual or recurrent cancer in its earliest stages, and this study shows the clinical importance of that ultra-sensitive detection in early-stage lung cancer.

A groundbreaking medical machine could be the key to early detection for lung cancer. Politician suffers stroke live on air during interview NRL fans react after Allana Ferguson backs Greg Inglis ...

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, according to the CDC.